Pages that link to "Q33891067"

The following pages link to N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier (Q33891067):

Displaying 20 items.

• Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy (Q26780520) (← links)
• Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference (Q28486133) (← links)
• Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET (Q34572780) (← links)
• Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients (Q35744147) (← links)
• The Inhibitor Ko143 Is Not Specific for ABCG2 (Q35962045) (← links)
• The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). (Q36015358) (← links)
• Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography (Q36049576) (← links)
• Advances in PET imaging of P-glycoprotein function at the blood-brain barrier (Q36638627) (← links)
• PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo (Q36953090) (← links)
• (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. (Q37177013) (← links)
• Overlapping substrate and inhibitor specificity of human and murine ABCG2. (Q37193073) (← links)
• Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2 (Q37409373) (← links)
• Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions. (Q38844653) (← links)
• Imaging transporters: Transforming diagnostic and therapeutic development (Q38871905) (← links)
• Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain. (Q39285381) (← links)
• Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide (Q39437473) (← links)
• Synthesis and in vivo evaluation of 18F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters (Q39615712) (← links)
• (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier (Q41823129) (← links)
• Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants. (Q50856395) (← links)
• ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas (Q92257741) (← links)